President Javier Milei received a delegation of senior executives from Bayer, one of the world's leading pharmaceutical and life sciences companies, at the Casa Rosada on Monday, in a meeting aimed at strengthening the bond between Argentina and the private sector.
During the meeting, Stefan Oelrich, global president of the Pharmaceutical Division and member of Bayer's Executive Board; Laura Diéguez Otero, Global Director of Government Affairs; Luciano Viglione, director of Bayer Southern Cone; and Horacio Oyhanarte, a member of the company's regional leadership, participated.
The Government continues to strengthen ties with international companies
From the national government, Secretary of Finance, Pablo Quirno, and Minister of Health, Mario Lugones, also attended the meeting with the President.
The Government continues to strengthen the bond with international companies
The meeting is part of Milei's administration strategy to consolidate a favorable climate for private investments, promoting dialogue with multinational companies operating in strategic sectors for the Argentine economy.
The pharmaceutical industry is one of the sectors with the greatest capacity for investment, innovation, and the generation of qualified employment, which is why the government seeks to deepen its relationship with the leading companies in the field.
The Milei administration aims to attract investments
Milei's administration aims to attract investments
Since the beginning of his administration, Javier Milei has promoted an agenda focused on economic openness, macroeconomic stability, and creating conditions for new investments to come to the country.
In this context, meetings with executives from leading companies are part of a policy aimed at strengthening private sector confidence and consolidating Argentina as an attractive destination for long-term project development.
